№ files_lp_3_process_7_076894
File format: docx
Character count: 3275
File size: 2101 KB
Weekly institutional newsletter outlining scheduled events, educational activities, workshops, tours, and contact information for families associated with the Child Development Centers of Bristol-Myers Squibb for the week of October 3, 2016.
Organization:
Child Development Center for Bristol-Myers Squibb
Date:
Monday, October 3, 2016
Type of document:
Weekly newsletter
Region:
United States
Programs mentioned:
Preschool/Kindergarten (PS/K)
Events:
Picture Day; Parent Partnership Call; Music for PS/K; Field Trip to Windsor Farm; Read for the Record; Harvest Festival; Homefront Food Drive
Workshops:
Weekly pregnancy workshop by March of Dimes
Location details:
Lawrenceville and Hopewell Child Development Centers
Contacts:
Kelli Mueller; Cyndi Guler; Jessica Goldfarb; Kim Murillo
Related platform:
Yammer (U.S. Work/Life Programs)
Curriculum reference:
Bright Horizons – The World at Their Fingertips®
Audience:
Families of enrolled children
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Australia
Topic:
Oncology, Urothelial carcinoma, Immunotherapy
Document type:
Medical submission
Organization / Institution:
Bristol-Myers Squibb Australia Pty Ltd
Author:
Unknown
Target audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval date:
2023
Date of amendments:
N/A
Source:
TGA/PBAC Parallel Process
Indication:
First-line treatment for unresectable or metastatic urothelial carcinoma
Treatment phase:
Initial and Continuing treatment
Condition:
Unresectable or metastatic urothelial carcinoma
Treatment criteria:
Patient must meet specific clinical and therapeutic criteria
Year:
2022
Region / City:
Australia
Theme:
Oncology, Medical Treatment
Document Type:
Pharmaceutical Submission
Organization / Institution:
Bristol-Myers Squibb Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical professionals, Oncologists
Period of validity:
Ongoing
Approval Date:
4 July 2018
Date of Changes:
Not specified
Note:
Contextual Description
Year:
2021
Region / city:
Australia
Theme:
Cancer treatment
Document type:
Submission for Authority Required listing
Organization / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Bristol-Myers Squibb Australia Pty Ltd
Target audience:
Medical practitioners
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Cancer Treatment / Immunotherapy
Document Type:
Submission
Organ / Institution:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Bristol-Myers Squibb
Target Audience:
Medical professionals, healthcare policy makers, pharmaceutical industry stakeholders
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025
Region / City:
Australia
Subject:
Myelofibrosis treatment
Document Type:
Pharmaceutical Submission
Organization / Institution:
Services Australia
Author:
Unknown
Target Audience:
Medical Practitioners
Period of Validity:
N/A
Approval Date:
February 13, 2025
Modification Date:
N/A
Year:
2023
Region / City:
Australia
Topic:
Oncology, Urothelial carcinoma, Immunotherapy
Document type:
Medical submission
Organization / Institution:
Bristol-Myers Squibb Australia Pty Ltd
Author:
Unknown
Target audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval date:
2023
Date of amendments:
N/A
Source:
TGA/PBAC Parallel Process
Indication:
First-line treatment for unresectable or metastatic urothelial carcinoma
Treatment phase:
Initial and Continuing treatment
Condition:
Unresectable or metastatic urothelial carcinoma
Treatment criteria:
Patient must meet specific clinical and therapeutic criteria
Year:
2022
Region / City:
Australia
Theme:
Oncology, Medical Treatment
Document Type:
Pharmaceutical Submission
Organization / Institution:
Bristol-Myers Squibb Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical professionals, Oncologists
Period of validity:
Ongoing
Approval Date:
4 July 2018
Date of Changes:
Not specified
Note:
Contextual Description
Year:
2021
Region / city:
Australia
Theme:
Cancer treatment
Document type:
Submission for Authority Required listing
Organization / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Bristol-Myers Squibb Australia Pty Ltd
Target audience:
Medical practitioners
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Cancer Treatment / Immunotherapy
Document Type:
Submission
Organ / Institution:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Bristol-Myers Squibb
Target Audience:
Medical professionals, healthcare policy makers, pharmaceutical industry stakeholders
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Date:
August 29, 2025
Location:
Florence, South Carolina
Organization:
HopeHealth
Sponsor:
Bristol Myers Squibb
Type of document:
Press release
Subject:
Launch of Phase 3 clinical trial site for systemic lupus erythematosus (SLE)
Clinical trial phase:
Phase 3
Investigational medication:
Deucravacitinib
Principal investigator:
Supen Patel
Chief medical officer:
Edward Behling
Corporate representative:
Andrew Whitehead
Disease focus:
Systemic lupus erythematosus (SLE)
Geographic focus:
Rural South Carolina, Pee Dee region
Participating population:
Patients with systemic lupus erythematosus
Issuing contact:
Monica Hanna, [email protected]
Note:
, (843) 432-2959
Year:
2023
Region / City:
Not specified
Topic:
Program Scope Change
Document Type:
Instruction Form
Organization:
Bristol Myers Squibb
Author:
Not specified
Target Audience:
Requestors submitting program change requests
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Contextual Description:
Instruction form for submitting program scope change requests to Bristol Myers Squibb.
Year:
2025
Region / City:
Australia
Subject:
Myelofibrosis treatment
Document Type:
Pharmaceutical Submission
Organization / Institution:
Services Australia
Author:
Unknown
Target Audience:
Medical Practitioners
Period of Validity:
N/A
Approval Date:
February 13, 2025
Modification Date:
N/A
Year:
2024
Region / City:
Imperial Pines
Topic:
Community Updates, Events, Safety
Document Type:
Newsletter
Organization:
Imperial Pines Condominium Association
Author:
Not specified
Target Audience:
Residents of Imperial Pines Condominium
Period of Action:
March 2024
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Victoria, Australia
Theme:
Gender equality in sports media, women’s sports coverage
Document Type:
Research study
Organization / Institution:
Victorian Government
Author:
N/A
Target Audience:
General public, media professionals, sports enthusiasts
Period of validity:
2023
Approval Date:
N/A
Date of Changes:
N/A
Note:
Date
Region / City:
Newport News
Topic:
Child Protective Services
Document Type:
Intake Form
Agency:
Newport News Department of Human Services
Target Audience:
Social workers, child welfare professionals
Contextual Description:
A form for reporting suspected child abuse or neglect to the Newport News Department of Human Services, intended for use by social workers and other professionals.
Year:
2019
Region / City:
Australia
Topic:
Healthcare, Veterans Affairs
Document Type:
Announcement
Organization / Institution:
Department of Veterans Affairs (DVA)
Author:
Not specified
Target Audience:
Allied health practitioners, healthcare providers
Effective Period:
From October 1, 2019
Approval Date:
Not specified
Date of Changes:
October 1, 2019
Year:
Year
Region / City:
CITY, State
Theme:
Healthcare Accreditation
Document Type:
Press Release
Organization / Institution:
Joint Commission
Author:
Not specified
Target Audience:
Healthcare organizations, medical professionals
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Region / City:
Newport News
Topic:
Child Protective Services
Document Type:
Intake Form
Organization / Institution:
Newport News Department of Human Services
Target Audience:
Social Workers, Child Protection Professionals
Contextual Description:
A form used by the Newport News Department of Human Services to document and report suspected cases of child abuse or neglect.
Year:
2020
Region / city:
Global
Topic:
Health emergencies, medical products, vaccine, therapeutics, diagnostics
Document type:
WHO Procedural Document
Organization:
World Health Organization
Author:
World Health Organization
Target audience:
UN procurement agencies, Member States, health product manufacturers
Action period:
2020 onwards
Approval date:
9 January 2020
Change date:
Not indicated
Year:
Not specified
Region / City:
Sarasota, FL
Topic:
Journalism, Television News
Document Type:
Resume
Organization / Institution:
Not specified
Author:
Rick Adams
Target Audience:
Potential Employers, News Stations
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified